CGP38560 Pages on BioPortfolio:

BioPortfolio - CGP38560
At Ciba-Geigy (now Novartis), the clinical development of the CGP38560 renin inhibitor was halted due to insufficient pharmacokinetics. ...
http://www.bioportfolio.com/search/CGP38560.html...

BioPortfolio - synergix Limited
At Ciba-Geigy (now Novartis), the clinical development of the CGP38560... 26th March, 2008, Synergix Ltd, Technology Park, Building #1, Jerusalem 91487, ...
http://www.bioportfolio.com/biocorporate/9930-synergix_Limit...

BioPortfolio - CHROMagar
COM | CGP38560 | biological E hyderabad telephone | ZETA PHARMACEUTICALS LLC. .. . http://www.bioportfolio.com/search/Robert_M_Streicher.html. ...
http://www.bioportfolio.com/search/CHROMagar.html...

Results from other life science and pharmaceutical sites:

Structure-based drug design and the discovery of a...[Chem Biol ...
At Ciba-Geigy (now Novartis), the clinical development of the CGP38560 renin inhibitor was halted due to insufficient pharmacokinetics. ...
http://www.ncbi.nlm.nih.gov/pubmed/17999663...

Advances in Structure-Based Drug Design
For this purpose, a homology model of the enzyme was used to characterize the binding mode of a peptide compound, CGP38560, in complex with a model of renin
...
http://www.genengnews.com/articles/chitem_print.aspx?aid=214...

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.